Dalan S. Bailey

Ash Road
Pirbright, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 100 publications

Copper(II) benzyloxychalcone analogues as new potential metallodrugs against SARS-CoV-2 replication.

Copper(II) benzyloxychalcone analogues as new potential metallodrugs against SARS-CoV-2 replication.

Journal: The Journal of general virology

Published: May 05, 2026

Assessment of human immunity to A/H3N2 influenza subclade K during 2025 emergence.

Assessment of human immunity to A/H3N2 influenza subclade K during 2025 emergence.

Journal: EBioMedicine

Published: March 16, 2026

Characterisation of Naturally Occurring MERS-CoV Spike Mutations and Their Impact on Fusion and Neutralisation.

Characterisation of Naturally Occurring MERS-CoV Spike Mutations and Their Impact on Fusion and Neutralisation.

Journal: Viruses

Published: February 20, 2026

An ultra-long heavy chain bovine antibody neutralizes SARS-CoV-2 and reacts broadly with sarbecoviruses.

An ultra-long heavy chain bovine antibody neutralizes SARS-CoV-2 and reacts broadly with sarbecoviruses.

Journal: bioRxiv : the preprint server for biology

Published: August 12, 2025

Heart-nosed bat alphacoronaviruses use human CEACAM6 to enter cells.

Heart-nosed bat alphacoronaviruses use human CEACAM6 to enter cells.

Journal: Nature

Published: July 23, 2025

Identifying an evolutionary origin for morbilliviruses in bats.

Identifying an evolutionary origin for morbilliviruses in bats.

Journal: Nature microbiology

Published: June 04, 2025

Distribution of aminopeptidase N coronavirus receptors in the respiratory and digestive tracts of domestic and wild artiodactyls and carnivores.

Distribution of aminopeptidase N coronavirus receptors in the respiratory and digestive tracts of domestic and wild artiodactyls and carnivores.

Journal: The Journal of general virology

Published: April 04, 2025

Nipah virus vaccines evaluated in pigs as a 'One Health' approach to protect public health.

Nipah virus vaccines evaluated in pigs as a 'One Health' approach to protect public health.

Journal: NPJ vaccines

Published: February 24, 2025

Estimating population immunity to SARS-CoV-2 by random sampling from primary and secondary healthcare in Scotland, May 2024.

Estimating population immunity to SARS-CoV-2 by random sampling from primary and secondary healthcare in Scotland, May 2024.

Journal: EBioMedicine

Published: November 15, 2024

Cross-protectivity of henipavirus soluble glycoprotein in an in vivo model of Nipah virus disease.

Cross-protectivity of henipavirus soluble glycoprotein in an in vivo model of Nipah virus disease.

Journal: Frontiers in immunology

Published: October 25, 2024

Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya.

Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya.

Journal: BMC infectious diseases

Published: July 29, 2024

Risk factors for severe COVID-19 disease increase SARS-CoV-2 infectivity of endothelial cells and pericytes.

Risk factors for severe COVID-19 disease increase SARS-CoV-2 infectivity of endothelial cells and pericytes.

Journal: Open biology

Published: June 11, 2024

Showing 1-12 of 100

Last Updated: 09/26/2026